-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide
Constipation is a (group) symptom characterized by difficulty with bowel movements and/or decreased frequency of bowel movements and dry and hard
stools.
Dysfecation includes laborious bowel movements, difficulty passing bowels, feeling incomplete, anorectal blockage, time-consuming bowel movements, and the need for assisted bowel
movements.
Reduced bowel movements are defined as fewer than 3 bowel movements per week
.
The course of chronic constipation is at least 6 months
.
Constipation seriously affects the daily life and quality of life of patients, and the treatment methods of chronic constipation mainly include: (1) general treatment: increase dietary fiber and water intake, increase exercise, establish good bowel habits, etc.
; (2) drug treatment; (3) biofeedback therapy; (4) Surgical treatment
.
Among them, drugs are commonly used treatment methods for chronic constipation, and the evidence-based medical evidence, safety, drug dependence and potency ratio
of drug application should be considered when selecting therapeutic drugs.
This article summarizes
the commonly used laxatives in clinical practice.
cathartic
Volumetric laxatives and osmotic laxatives are mainly used in patients with
mild to moderate constipation.
(1) Volumetric laxative (leavening agent)
By retaining water in the feces, increasing the water content and volume of the feces plays a laxative role, so that the dry and hard feces become soft and easy to excrete
.
Commonly used drugs: psyllium, polycarbo noncalcium, wheat bran, etc
.
(2) osmotic laxatives
After oral administration, it can form a hypertonic state in the intestine to absorb water, and at the same time prevent the intestine from absorbing water, resulting in increased intestinal content volume, promoting intestinal peristalsis, and causing bowel
movements.
Commonly used drugs: polyethylene glycol, unabsorbed sugars (such as lactulose), salt laxatives (such as magnesium sulfate), etc
.
It should be noted that excessive use of salt laxatives can cause electrolyte imbalance, and should be used
with caution in the elderly and patients with reduced renal function.
As a remedy, stimulant laxatives can be used for short-term, intermittent use
.
(3) Stimulant laxatives
Mainly by stimulating the sensory nerve endings in the colonic mucosa, enhancing colonic motility, and stimulating intestinal secretion, thereby promoting bowel movements, its effect is strong and rapid, can cause abdominal pain
.
Commonly used drugs: bisacodyl, phenolphthalein, anthraquinones, castor oil, etc
.
(4) Lubricating laxatives
It has the effect of softening feces and lubricating the intestinal wall so that feces are easy to discharge
.
Commonly used drugs: liquid paraffin, glycerin, docusate sodium and other vegetable oils
.
Prokinetic drugs act on intestinal nerve endings, release motor neurotransmitters, antagonize inhibitory neurotransmitters or directly act on smooth muscle, increase intestinal motility, and have a good effect
on slow-transit constipation.
Commonly used drugs: pruka bili, etc
.
Guanyan cyclase-C (GC-C) agonist (representative drug: linalotide) can improve abdominal pain, constipation and other symptoms
in patients with chronic constipation.
Chloride channel activators (representative drug: rubiprostone) can promote intestinal epithelial secretion and increase the frequency of
spontaneous bowel movements in patients.
Enemas and suppositories
Commonly used suppositories are glycerol preparations (e.
g.
, Kaiserol).
Enemas are indicated for older patients
with constipation who have severe motility problems.
Microecological preparations
Available research data confirm that patients with chronic constipation have intestinal microbiome imbalance
.
Although microecological preparations are not first-line drugs for the treatment of chronic constipation, they can promote intestinal peristalsis and gastrointestinal motility recovery by regulating intestinal flora imbalance, and more and more researchers recommend them as long-term adjuvant drugs for chronic constipation
.
Microecological preparations can be divided into three categories: probiotics (such as bifidobacteria and lactobacilli, etc.
), prebiotics (such as inulin) and synbiotics (preparations containing both probiotics and prebiotics), and fecal bacteria transplantation therapy also belongs to the broad sense of intestinal microecological therapy
.
Traditional Chinese Medicine
Randomized, double-blind, placebo-controlled studies on the treatment of chronic constipation by traditional Chinese medicines have found that traditional Chinese medicines (including proprietary Chinese medicine preparations and decoctions) can effectively relieve the symptoms of chronic constipation, but more evidence-based medical evidence
is needed to evaluate their efficacy.
The 2022 American Association of Nurses (AANP) Evidence-Based Treatment Recommendations: Over-the-Counter Drug Management of Chronic Constipation provides comparative recommendations
for OTC products for chronic constipation at evidence-based medical grade levels.
References:
1.
Gastrointestinal Kinetics Group, Functional Gastroenterology Collaborative Group, Gastroenterology Branch of Chinese Medical Association.
Expert consensus opinion on chronic constipation in China (2019, Guangzhou)[J].
Chinese Journal of Digestion, 2019, 39(9):577-598.
2.
Liu Shi.
Reasonable choice of drug treatment for chronic constipation[J].
Chinese Journal of Internal Medicine, 2015(7):2.
3.
Rao SSC, Brenner DM.
Evidence-based treatment recommendations for OTC management of chronic constipation.
J Am Assoc Nurse Pract.
2022 Sep 1; 34(9):1041-1044.
doi: 10.
1097/JXX.
0000000000000760.
PMID: 35943487; PMCID: PMC9439685.